News

The FDA has issued revised guidelines impacting the operational frameworks of Contract Research Organizations.

A new collaborative initiative aims to diversify mRNA vaccine applications.

FDA announces new regulatory guidelines impacting biologics manufacturing processes.

A major pharmaceutical company has launched a cutting-edge cleanroom facility in Europe, enhancing its production capabilities.

Regulatory bodies announce new guidelines for drug manufacturing compliance to enhance industry standards.

IQVIA a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the bioplatform innovation company, today announced a strategic collaboration

Camurus today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Oczyesa®, octreotide subcutaneous depot, marketing authorization

Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved updated Risk Evaluation and Mitigation Strategy (REMS) labeling for FILSPARI® (sparsentan),

Sandoz the global leader in generic and biosimilar medicines, today announced the launch of generic rivaroxaban in Germany, in new generic strengths of 10 mg, 15 mg and 20 mg. Rivaroxaban - 1 A Pharma® offers patients

MannKind Corporation and scPharmaceuticals Inc. (Nasdaq: SCPH) today announced the signing of a definitive merger agreement for MannKind to acquire scPharmaceuticals.